Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Health Care Cost
96%
Global Disease Burden
35%
Quality Adjusted Life Year
28%
Disease
26%
Systematic Review
22%
Prevalence
15%
Health Care
15%
Infection
13%
Quality of Life
13%
Disability Adjusted Life Years
12%
Human Immunodeficiency Virus
11%
Rotavirus
11%
Diabetes
10%
Influenza Vaccination
9%
Wart Virus
9%
Low and Middle Income Countries
9%
COVID-19
9%
Influenza Vaccine
9%
Mortality Rate
8%
Primary Health Care
8%
Screening
8%
Injury
8%
Medicine
8%
Malignant Neoplasm
7%
Cervical Cancer
7%
Base
7%
Respiratory Tract Infection
7%
Drug Therapy
7%
Maturity Onset Diabetes of the Young
7%
Diagnosis
7%
Atrial Fibrillation
7%
Childbirth
6%
Decision Making
6%
Life Expectancy
6%
Health Technology
6%
Technology Assessment
6%
Apoplexy
5%
Pneumococcus Vaccine
5%
Public Health
5%
Diarrhea
5%
Cost Benefit Analysis
5%
Antibiotics
5%
Outpatient
5%
Chronic Obstructive Pulmonary Disease
5%
Chlamydia Trachomatis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
77%
Disease
40%
Pharmacoeconomics
33%
Global Disease Burden
28%
Prevalence
22%
Infection
21%
HIV
16%
Base
15%
Rotavirus
15%
Live Attenuated Influenza Vaccine
14%
Non Insulin Dependent Diabetes Mellitus
13%
Chronic Obstructive Lung Disease
11%
Atrial Fibrillation
10%
Malignant Neoplasm
10%
Cardiovascular Disease
9%
Human Papillomavirus
9%
Chlamydia Trachomatis
8%
Influenza Vaccine
8%
Pneumococcus Vaccine
7%
Statin (Protein)
7%
Injury
7%
Antivitamin K
6%
Antibiotics
6%
Asthma
6%
Uterine Cervix Cancer
6%
Pharmacotherapy
6%
Clinical Trial
6%
Mortality Rate
6%
Hepatitis B Virus
5%
Randomized Controlled Trial
5%
Cohort Study
5%
Cross-Sectional Study
5%
Pneumococcal Infection
5%
Symptom
5%
Hepatitis C Virus
5%
Diabetes Mellitus
5%
Apixaban
5%
Dabigatran
5%
Keyphrases
Cost-effectiveness
39%
Netherlands
31%
Dutch
15%
Cost-effectiveness Analysis
15%
Quality-adjusted Life Years
11%
Indonesia
9%
Economic Evaluation
9%
Incremental Cost-effectiveness Ratio
7%
Global Burden of Disease Study
7%
Cost Savings
6%
Vaccination
6%
Global Burden of Disease 2019
6%
Influenza Vaccination
5%
Pharmacoeconomics
5%
Hospitalization
5%
Health Economics
5%
Disability-adjusted Life Years
5%
Older Adults
5%
Sensitivity Analysis
5%
